Methods and compositions for vitamin K epoxide reductase

Details Methods and compositions for vitamin K epoxide reductase Methods and compositions for vitamin K epoxide reductase

2009-01-28

2010-12-28

Sitton, Jehanne S (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C536S023100, C536S024300

Reexamination Certificate

active

07858318

ABSTRACT:
The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide polymorphism in the VKOR gene, wherein the single nucleotide polymorphism is correlated with increased or decreased sensitivity to warfarin, thereby identifying the subject having increased or decreased sensitivity to warfarin.

REFERENCES:
patent: 4736866 (1988-04-01), Leder et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5547835 (1996-08-01), Koster et al.
patent: 5583278 (1996-12-01), Alt et al.
patent: 5625122 (1997-04-01), Mak
patent: 5686631 (1997-11-01), Li et al.
patent: 5698765 (1997-12-01), Mak
patent: 5750825 (1998-05-01), Yazaki et al.
patent: 6043031 (2000-03-01), Koster et al.
patent: 6453244 (2002-09-01), Oefner
patent: 6492115 (2002-12-01), Guida et al.
patent: 7445896 (2008-11-01), Rieder et al.
patent: 2005/0164367 (2005-07-01), Fenge et al.
patent: 2005/0271644 (2005-12-01), Oldenburg et al.
patent: 2006/0084070 (2006-04-01), Rieder et al.
patent: 2006/0084081 (2006-04-01), Rieder et al.
patent: 2006/0166239 (2006-07-01), Chen et al.
patent: 2006/0194284 (2006-08-01), Scheiflinger et al.
patent: 2006/0240440 (2006-10-01), Stafford et al.
patent: 2007/0009950 (2007-01-01), Stafford et al.
patent: 2007/0190614 (2007-08-01), Stafford et al.
patent: 2007/0269866 (2007-11-01), Stafford et al.
patent: 2007/0298426 (2007-12-01), Chen et al.
patent: 2008/0050732 (2008-02-01), Rieder et al.
patent: 2008/0050733 (2008-02-01), Rieder et al.
patent: 2008/0057500 (2008-03-01), Rieder et al.
patent: 2008/0318219 (2008-12-01), Rieder et al.
patent: 0 127 839 (1984-12-01), None
patent: 0 154 133 (1985-09-01), None
patent: 0 368 684 (1990-05-01), None
patent: 0 549 721 (1993-07-01), None
patent: WO 88/01649 (1988-03-01), None
patent: WO 89/12685 (1989-12-01), None
patent: WO 92/01795 (1992-02-01), None
patent: WO 93/06213 (1993-04-01), None
patent: WO 95/34679 (1995-12-01), None
patent: WO 97/49802 (1997-12-01), None
patent: WO 98/24884 (1998-06-01), None
patent: WO 99/33983 (1999-07-01), None
patent: WO 99/43003 (1999-08-01), None
patent: WO 00/03015 (2000-01-01), None
patent: WO 02/40544 (2002-05-01), None
patent: WO 02/102994 (2002-12-01), None
patent: WO 2005/030039 (2005-04-01), None
patent: WO 2005/040367 (2005-05-01), None
patent: WO 2006/044686 (2006-04-01), None
patent: WO 2006/067116 (2006-06-01), None
patent: WO 2006/089613 (2006-08-01), None
patent: WO 2006/101474 (2006-09-01), None
Kimura et al; Thrombosis research, vol. 120, pp. 181-186, 2007.
Rost et al; Nature vol. 427, pp. 537-541 Feb. 5, 2004.
dbSNP rs7294, build 86, NCBI; 2000.
Genbank Accession No: AC135050, 2002.
Chica et al. “Semi-Rational Approaches to Engineering Enzyme Activity: Combining the Benefits of Directed Evolution and Rational Design”Current Opinion in Biotechnology16:378-384 (2005).
GenBank Accession No. N63475 (2p)(Sep. 13, 2000).
GenBank Accession No. NT024812 (5p)(Jul. 4, 2003).
Hegele. “SNP Judgments and Freedom of Association”Arterioscler Thromb. Vasc. Biol.22:1058-1061 (2002).
Keller and Manak. “DNA Probes” 2ndEd., Macmillan Publishers Ltd., pp. 259 (1993).
Lucentini. “Gene Association Studies Typically Wrong” The Scientist pp. 20 (Dec. 20, 2004).
Risch. “Searching for Genetic Determinants in the New Millennium”Nature405:847-856 (2000).
Sen et al. “Developments in Directed Evolution for Improving Enzyme Functions”Appl. Biochem. Biotechnol.143:212-223 (2007).
European Search Report for Application EP 05733161.3, mailed Aug. 5, 2008 (4 pages).
European Search Report for Application EP 04789039.7, mailed Oct. 7, 2008 (6 pages).
Database Accession No. ADA57411 “Human Secreted Protein #230”, Nov. 20, 2003 (first entry)(reissued Jun. 15, 2007).
Fair et al. “Biosynthesis and Secretion of Factor VII, Protein C, Protein S, and the Protein C Inhibitor from a Human Hepatoma Cell Line”Blood67:64-70 (1986).
Ferland. “The Vitamin-K Dependent Proteins: An Update”Nutrition Reviews56(8):223-230 (1998).
Furie et al. “Molecular Basis of Vitamin K-Dependent y-Carboxylation”The Journal of the American Society of Hematology75:1753-1762 (1990).
Gainnelli et al. “Hemophilia B: Database of Point Mutations and Short Additions and Deletions—Eighth Edition”Nucleic Acids Research26(1):265-268 (1998).
Kulman et al. “Primary Structure and Tissue Distribution of Two Novel Proline-Rich γ-Carboxyglutamic Acid Proteins”Proc. Natl. Acad, Sci.USA 94:9058-9062 (1997).
McVey et al. “Factor VII Deficiency and the FVII Mutation Database”Human Mutation17:3-17 (2001).
Munns et al. “Vitamin K-Dependent Synthesis and Modification of Precursor Prothrombin in Cultured H-35 Hepatoma Cells”Proc. Natl. Acad. Sci. USA73:2803-2807 (1976).
Price et al. “Matrix Gla Protein, a New γ-Carboxyglutamic Acid-Containing Protein Which is Associated with the Organic Matrix of Bone”Biochemical and Biophysical Research Communications117(3):765-771 (1983).
Suttie. “Synthesis of Vitamin K-Dependent Proteins’FASEB J.7:445-452 (1993).
Tsaioun. “Vitamin K-Dependent Proteins in the Developing and Aging Nervous System”Nutrition Reviews57(8):231-240 (1999).
European Search Report for Application EP 070109353 mailed, Aug. 30, 2007.
Hanumanthaiah et al. “Developmental Expression of Vitamin K-Dependent Gamma-Carboxylase Activity in Zebrafish Embryos: Effect of Warfarin”Blood Cells, Molecules, and Diseases27(6):992-999 (2001).
Clark et al. “The Secreted Protein Discovery Initiative (SPDI), a large scale effort to identify novel human secreted and transmembrane proteins: a bioinformatic assessment”Genome Res. 13:2265-2270 (2003).
Specification of U.S. Appl. No. 11/787,072, filed Apr. 13, 2007, entitled “Methods and Compositions for Producing Vitamin K Dependent Proteins”.
Specification of U.S. Appl. No. 11/643,563, filed Dec. 21, 2006, entitled “Method of Producing Biologically Active Vitamin K Dependent Proteins by Recombinant Methods”.
GenBank Accession No. BC000828,Homo sapiensvitamin K epoxide reductase complex, CDNA clone IMAGE:3455200, Aug. 11, 2006.
GenBank Accession No. BC000828,Homo sapiensvitamin K epoxide reductase complex, CDNA clone IMAGE:3455200, Sep. 1, 2006.
GenBank Accession No. BC002911,Homo sapiensvitamin K epoxide reductase complex, clone MGC:11276, Jul. 15, 2006.
GenBank Accession No. BC002911,Homo sapiens, clone MGC:11276, Jul. 12, 2001.
GenBank Accession No. BC027734,Homo sapiensvitamin K epoxide reductase complex, clone MGC:29720, Jul. 15, 2006.
GenBank Accession No. NG—005631,Homo sapiensvitamin K epoxide reductase complex, LOC441241, Aug. 5, 2006.
GenBank Accession No. NM—178600,Mus musculusvitamin K epoxide reductase complex, Vkorc1, Aug. 6, 2006.
GenBank Accession No. NM024006.1,Homo sapienshypothetical protein, Image 3455200, Oct. 5, 2003.
GenBank Accession No. NM024006,Homo sapiensvitamin K epoxide reductase complex, VKORC1, Aug. 13, 2006.
GenBank Accession No. NM203335,Rattus norvegicusvitamin K epoxide reductase complex, Vkorc1, Jan. 15, 2006.
GenBank Accession No. NM206807.1,Gallus gallusvitamin K epoxide reductase complex, VKORC1, Jun. 25, 2006.
GenBank Accession No. NM206824.1,Homo sapiensvitamin K epoxide reductase complex, VKORC1, Aug. 13, 2006.
ICOS “Factor IX Cell Culture Process” Version 2.0 (12 pages) (2006).
Bogousslaysky et al. “Anticoagulant-induced intracerebral bleeding in brain ischemia”Acta Neurol Scand. 77:464-471 (1985).
Chen et al. “Calcium Phosphate-Mediated Gene Transfer: A Highly Efficient Transfection System for Stably Transforming Cells with Plasmid DNA”BioTechniques6(7):632-638 (1988).
Ekelund et al. “Combined Deficiency of Coagulation Factors II, VII, IX, and X: A Case of Probable Congeni

Affiliated with

Also associated with

Rating

Methods and compositions for vitamin K epoxide reductase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for vitamin K epoxide reductase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for vitamin K epoxide reductase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183899